Long-term effects of treatment with alendronate for patients with osteoporosis

被引：0

作者：

Nancy E Lane

机构：

[1] NE Lane is the Endowed Professor of Medicine and Rheumatology at the University of California,and the Co

[2] Davis Medical School,Vice

[3] Sacramento. She is also the Director of the Center for Healthy Aging,Chair for Research for the Department of Medicine at the University of California at Davis

[4] CA,undefined

[5] USA.,undefined

来源：

Nature Clinical Practice Rheumatology | 2007年 / 3卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：426 / 427

页数：1

共 4 条

[1]

Black DM(1996)Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535-1541

[2]

Cummings SR(1998)Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 2077-2082

[3]

Ensrud KE(2004)Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension J Bone Miner Res 19 1259-1269

[4]

Cummings SR(1995)Risk factors for hip fractures in white women. Study of Osteoporotic Fractures Research Group N Engl J Med 23 767-773

← 1 →